The LARA trial (NCT04699071), a multi-center, single-arm, phase 2 study, found that combining pembrolizumab (Keytruda) with ...

When it comes to cancer, knowledge is power, especially when it comes to screenings and prevention. In this segment, ...

Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...

There is a significant gap in patients’ understanding of treatment options for gynecologic cancers, according to a survey conducted by The Harris Poll on behalf of GSK. In a poll of more than 800 ...

Several drug classes, including immunotherapy, antibody-drug conjugates and PARP inhibitors have helped improve outcomes for gynecologic cancers. Over the past 10 years, PARP inhibitors, immunotherapy ...

"The robotic platform enables the successful completion of complex gynecologic oncology procedures for uterine cancers without conversion in 97.9% of 1407 consecutive, unselected cases. This allows ...

A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using stabilized hyaluronic acid (sHA) gel as a rectal spacer during radiation treatment ...

Approximately 100,000 women are diagnosed with gynecologic cancer every year in the United States. Cancer of the endometrium, or the lining of the uterus, is the most common cancer of a woman’s ...

“These are frequently lethal cancers if they’re found later on,” said Dr. J. Brian Szender, chief of Surgery at Methodist Stone Oak, he also the Gynecologic Oncology Program Director at the START ...

Qatar Cancer Society (QCS) has concluded its awareness campaign Together for Her, which targeted women across Qatari society as part ...

BUFFALO, N.Y. — Buffalo is one of six cities that have a branch of Pink Ribbon Good (PRG). Pink Ribbon Good is an organization who's mission is assisting those with Brest and Gynecological cancer.

Please provide your email address to receive an email when new articles are posted on . Clinical trial enrollment was lower for Asian, Black and Hispanic women vs. white women. Asian and Hispanic ...